S.316 - Federal Government
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. |
Committee on the Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights. Hearings held.03/07/2007
Committee on the Judiciary. Reported by Senator Leahy without amendment. Without written report.02/27/2007
Placed on Senate Legislative Calendar under General Orders. Calendar No. 59.02/27/2007- Committee on the Judiciary. Approved for reporting without amendment favorably.02/15/2007
- Committee on the Judiciary. Date of scheduled consideration. S-216. 10:00 a.m.02/15/2007
- Committee on the Judiciary. Date of scheduled consideration. SD-226. 10:00 a.m.02/08/2007
- Sponsor introductory remarks on measure. (CR S679)01/17/2007
Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S679-680)01/17/2007- Committee on the Judiciary. Hearings held.01/17/2007
ok 
cancel